Flexion Therapeutics Inc (NASDAQ:FLXN) investors have sent shares racing 38% on back of media buzz painting the arc of a prospective takeout, courtesy …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) continues to face a flurry of legal calamities, from a T. Rowe Price-issued suit to a separate class …
At a healthcare conference last week, Joe Papa, CEO of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) indicated that the troubled biotech giant would go …
Analyst David Maris of Wells Fargo weighs in on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) ahead of second-quarter earnings, stating that he doesn’t see any indication that the troubled drug maker …
